Cyclin E1 MGD(TRIANA Biomedicines Inc)

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameCyclin E1 MGD(TRIANA Biomedicines Inc)
Drug Alias NameN/A
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionG1/S-specific cyclin-E1 degraders
TargetsG1/S-specific cyclin-E1
Therapy Area/IndicationsSolid tumoursHR-positive breast cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTRIANA Biomedicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesTRIANA Biomedicines Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursHR-positive breast cancer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A